Connect with us

NEWS

India recommends Covaxin vs Covid-19 vaccine for children 2 years and older

Published

on


The country has fully vaccinated about 29% of the 944 million eligible adults, according to government data, which includes the application of more than 110 million doses of Covaxin, from Bharat Biotech.

The company, however, is still in the process of getting its name on a World Health Organization emergency use list, a move expected later this month.

Without WHO approval, the two-dose vaccine is unlikely to be accepted as a valid vaccine worldwide.

Several countries have made efforts to authorize vaccines for children. The United States has released Pfizer’s vaccine for children ages 12 and older, and the U.S. regulator’s advisory group will meet later this month to discuss the vaccine for children ages 5 to 11.

Although Covid-19 is known to generally cause mild illness in children, there is a risk of rare post-illness complications.

“Children with comorbidities should be vaccinated as soon as possible now that a vaccine with immunogenicity in children and a large safety database for adults is available,” said Dr. Gagandeep Kang, professor at Christian Medical College , Vellore.

Videos: the most viewed g1 in the last 7 days

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Advertisement

Recent Posts

Trending